Florida Atlantic University is recruiting participants for an exciting research study aimed at understanding the effects of Parkinson’s disease (PD) and normal aging on cognitive performance, exercise ability and the mind-body connection.
This study will compare the cognitive and exercise performance of individuals with and without PD to gain insights into mobility and cognitive function across different age groups. The primary goal is to explore the differences in cognitive and exercise performance between individuals diagnosed with PD and healthy aging controls, focusing on how aging and PD uniquely impact cognitive and physical function.
To participate, individuals with PD must be 62 years of age or older, have a diagnosis of PD, and have no recent changes in PD medications. Participants should also be physically active within the community and not use assistive devices such as a cane or walker for mobility.
For healthy controls, participants must be 62 years of age or older, have no neurological diagnoses, and have no recent changes in medications. They should also be physically active within the community and not use assistive devices for mobility.
All participants who qualify for the study will visit FAU’s Boca Raton campus for one testing session, which will last approximately one hour. During the session, participants will undergo cognitive and exercise assessments, including the Stroop test, Flanker test, Senior Fitness Test, and will complete questionnaires.
Participants will be assessed on their balance and fall risk potential and will gain valuable insights into their cognitive and exercise performance.
“Our study offers a unique opportunity to contribute to advancing research that could help improve the quality of life for individuals with Parkinson’s disease, providing valuable insights into more effective treatments,” said B. Sue Graves, Ed.D., principal investigator and an associate professor in the Department of Exercise Science and Health Promotion within the FAU Charles E. Schmidt College of Science. “Additionally, it enhances our understanding of healthy aging, which is critical for developing strategies that promote well-being throughout the lifespan.”
For more information, email sgraves@fau.edu or call 954-675-5782.
-FAU-
Latest News Desk
- FAU Hosts Second Annual FairfaxWood Amyloid Related Diseases SummitFAU's Charles E. Schmidt College of Medicine recently hosted the summit, bringing together top scientists from North America and Europe to discuss the latest amyloid research and advancements.
- FAU Sensing Institute's Weather Network Brings Real-time ForecastingFAU I-SENSE is storm ready with SEA Econet, a cutting-edge weather network stretching from Key West to South Carolina, delivering real-time data to boost forecasting accuracy and strengthen coastal resilience.
- 'Eye' on Health: AI Detects Dizziness and Balance Disorders RemotelyFAU researchers and collaborators have developed a cost-effective, AI-powered system for diagnosing nystagmus - a condition causing involuntary eye movements - using smartphone videos and cloud-based analysis.
- Study Explores Barriers and Trends in Cannabis Use Disorder TreatmentA study over a 16-year period by FAU researchers shows a troubling decline in treatment for cannabis use disorder and reveals why most people with the disorder don't seek help.
- FAU Achieves R1 Status, Receive Carnegie Opportunity DesignationFlorida Atlantic University has been recognized for its leadership on two essential fronts: advancing science and discovery for the nation and prioritizing student access and success.
- Fixing the Leak: An Opioid Treatment for Dopamine Disorders?A breakthrough by FAU researchers shows that blocking the kappa opioid receptor improves behavioral deficits tied to ADHD, autism and bipolar disorder, providing a potentially safer yet effective treatment.